Helsana
Zurich, Switzerland
NCT Number: NCT03213327
The validity and the sensitivity of different measures implemented in the web application StayOk are investigated. The measures are used primarily for the assessment and the early identification of psychosocial risks. Secondarily, the results of the assessment are applied to generate health-promoting advices for the user of the web application.
Looking for future studies?
Notify Me16 year–65 year
All sexes
Interventional
Not applicable
Zurich, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients fill in the questionnaires of the web application and receive an analyzed profile of their psychosocial condition and health-promoting advices
Time frame: 0 week (first assessment)
The psychological distress is assessed by the Brief Symptom Inventory (BSI; Derogatis & Melisaratos, 1983)
Time frame: 0 weeks
The work-related sense of coherence is assessed by the Work Sense of Coherence (W-SoC 9; Jenny et al., 2016)
Time frame: 0 weeks
This aspect is measure by the General Self-Efficacy Scale (GSE; Damásio et al., 2016)
Time frame: 12 weeks after the first assessment
The effectiveness of the advices generated by the software is assessed by means of a self-developed questionnaire: Participants are inquired as to (1) whether they put in practice the advices and (2) how they evaluate the benefit of the applied advices and the consequent satisfaction.
Zurich University of Applied Sciences
Other
Acronym: StayOK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04543097
Absence, Behavior
Newcastle-under-Lyme, United Kingdom
View Trial DetailsNCT05753423
Behavior, Mental Disorders
Cairo, Egypt
View Trial DetailsNCT06213194
Autism Spectrum Disorder, Autism or Autistic Traits
Istanbul, Basaksehir, Turkey (Türkiye)
View Trial DetailsNCT05282173
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Cape Town, Western Cape, South Africa
View Trial Details